All participants will be awarded a certificate of completion for self-reporting to other colleges
Duration: 30 minutes
Did you know that excessive use of acute headache medications may be the culprit for frequent headaches? Learn about MOH, its diagnostic criteria and pathophysiology, and the medications associated with
Upon completing this course, participants will be able to:
define MOH based on the criteria of the International Classification of Headache Disorders (ICHD 3rd edition);
list the symptoms associated with primary headaches;
explain the pathophysiology of MOH based on a number of theories on its precise mechanism;
formulate a system that would remind prescribers of which headache medications can present high to moderate risk for MOH.
Associate Professor Richard Stark: Co-authored a clinical paper sponsored by Pfizer on the safety of eletriptan. Between 2012 and 2014 received consulting and lecture fees from Allergan and lecture fees from MSD on chronic migraine
Professor Mieke Van Driel: No conflict of interest
Associate Professor Treasure McGuire: No conflict of interest
Dr Brett McFarlane: No conflict of interest
Professor Deborah Turnbull: Received research grants and co-authored papers on hypertension sponsored by pharmaceutical companies, including Pfizer Pty. Ltd., between 1999 and 2006
Dr Lara Mihaljevic: No conflict of interest
Non-faculty: employees of In Vivo Academy involved in producing the content of this course, Yulyana, Tina Garcia, Monica Kurniawan and Lisa Sullivan, declare no conflict of interest.